Using genetics, researchers identify potential drugs for early treatment of COVID-19
E-Mail IMAGE: Dr. Juan P. Casas, a physician epidemiologist, led the study, which called for prioritizing clinical trials of drugs targeting two proteins. view more Credit: Frank Curran A new study using human genetics suggests researchers should prioritize clinical trials of drugs that target two proteins to manage COVID-19 in its early stages. The findings appeared online in the journal Nature Medicine in March 2021. Based on their analyses, the researchers are calling for prioritizing clinical trials of drugs targeting the proteins IFNAR2 and ACE2. The goal is to identify exis...